The company's flagship product, Harmony SHR, is a bilateral, upper extremity exoskeleton that facilitates data-driven treatment for neurological and musculoskeletal movement impairments. It enables early intervention, increases functional repetition, and employs patient-specific intent-based therapy through novel exercises. Harmony SHR also provides unique value in neuroscience and movement science research, movement disorder assessment, and rehabilitation, with its multi-plane movements and bilateral design opening up new research possibilities. The system's data capabilities enable researchers and caregivers to optimize the treatment process for patients suffering from movement disorders by measuring functionality at baseline and throughout the recovery process. Harmony's different modes of therapy also help address patients throughout the care continuum.